Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature

Research output: Contribution to journalArticle

Abstract

Visceral leishmaniasis has been recognized as an opportunistic infection affecting people with cellular-immunity impairment, including hematopoietic cell transplantation (HCT) recipients. We describe the case of a young Italian man with Hodgkin lymphoma, who developed visceral leishmaniasis after multiple lines of chemotherapy and allogenic HCT. Literature review of visceral leishmaniasis in HCT recipients was also performed. Eleven patients (median age 50 years, 9 male) developed visceral leishmaniasis after allogenic (n = 9) and autologous (n = 2) HCT. Most of them presented with fever and pancytopenia. Bone marrow examination was the main diagnostic technique; liposomal amphotericin B was the treatment of choice. Four out of eight patients (for whom data are available) experienced visceral leishmaniasis relapse. Visceral leishmaniasis in HCT recipients is a rare event that should be suspected in patients with persistent fever, pancytopenia and possible exposure to Leishmania spp., remembering that – as well as South-East Asia, East Africa and South America - it is endemic in several European regions.

Original languageEnglish
JournalJournal of Infection and Chemotherapy
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Visceral Leishmaniasis
Cell Transplantation
Pancytopenia
Fever
Bone Marrow Examination
Eastern Africa
Far East
South America
Leishmania
Opportunistic Infections
Hodgkin Disease
Cellular Immunity
Recurrence
Drug Therapy

Keywords

  • Bone marrow
  • Fever
  • Hematopoietic cell transplantation
  • Leishmania spp.
  • Pancytopenia
  • Visceral leishmaniasis

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

@article{0e1ff40c87e245e996e80f6d529ccce6,
title = "Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature",
abstract = "Visceral leishmaniasis has been recognized as an opportunistic infection affecting people with cellular-immunity impairment, including hematopoietic cell transplantation (HCT) recipients. We describe the case of a young Italian man with Hodgkin lymphoma, who developed visceral leishmaniasis after multiple lines of chemotherapy and allogenic HCT. Literature review of visceral leishmaniasis in HCT recipients was also performed. Eleven patients (median age 50 years, 9 male) developed visceral leishmaniasis after allogenic (n = 9) and autologous (n = 2) HCT. Most of them presented with fever and pancytopenia. Bone marrow examination was the main diagnostic technique; liposomal amphotericin B was the treatment of choice. Four out of eight patients (for whom data are available) experienced visceral leishmaniasis relapse. Visceral leishmaniasis in HCT recipients is a rare event that should be suspected in patients with persistent fever, pancytopenia and possible exposure to Leishmania spp., remembering that – as well as South-East Asia, East Africa and South America - it is endemic in several European regions.",
keywords = "Bone marrow, Fever, Hematopoietic cell transplantation, Leishmania spp., Pancytopenia, Visceral leishmaniasis",
author = "P. Tatarelli and G. Fornaro and {Del Bono}, V. and Nicolini, {L. A.} and Raiola, {A. M.} and F. Gualandi and R. Varaldo and {Di Muccio}, T. and M. Gramiccia and L. Gradoni and E. Angelucci and C. Viscoli and M. Mikulska",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jiac.2018.05.008",
language = "English",
journal = "Journal of Infection and Chemotherapy",
issn = "1341-321X",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Visceral leishmaniasis in hematopoietic cell transplantation

T2 - Case report and review of the literature

AU - Tatarelli, P.

AU - Fornaro, G.

AU - Del Bono, V.

AU - Nicolini, L. A.

AU - Raiola, A. M.

AU - Gualandi, F.

AU - Varaldo, R.

AU - Di Muccio, T.

AU - Gramiccia, M.

AU - Gradoni, L.

AU - Angelucci, E.

AU - Viscoli, C.

AU - Mikulska, M.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Visceral leishmaniasis has been recognized as an opportunistic infection affecting people with cellular-immunity impairment, including hematopoietic cell transplantation (HCT) recipients. We describe the case of a young Italian man with Hodgkin lymphoma, who developed visceral leishmaniasis after multiple lines of chemotherapy and allogenic HCT. Literature review of visceral leishmaniasis in HCT recipients was also performed. Eleven patients (median age 50 years, 9 male) developed visceral leishmaniasis after allogenic (n = 9) and autologous (n = 2) HCT. Most of them presented with fever and pancytopenia. Bone marrow examination was the main diagnostic technique; liposomal amphotericin B was the treatment of choice. Four out of eight patients (for whom data are available) experienced visceral leishmaniasis relapse. Visceral leishmaniasis in HCT recipients is a rare event that should be suspected in patients with persistent fever, pancytopenia and possible exposure to Leishmania spp., remembering that – as well as South-East Asia, East Africa and South America - it is endemic in several European regions.

AB - Visceral leishmaniasis has been recognized as an opportunistic infection affecting people with cellular-immunity impairment, including hematopoietic cell transplantation (HCT) recipients. We describe the case of a young Italian man with Hodgkin lymphoma, who developed visceral leishmaniasis after multiple lines of chemotherapy and allogenic HCT. Literature review of visceral leishmaniasis in HCT recipients was also performed. Eleven patients (median age 50 years, 9 male) developed visceral leishmaniasis after allogenic (n = 9) and autologous (n = 2) HCT. Most of them presented with fever and pancytopenia. Bone marrow examination was the main diagnostic technique; liposomal amphotericin B was the treatment of choice. Four out of eight patients (for whom data are available) experienced visceral leishmaniasis relapse. Visceral leishmaniasis in HCT recipients is a rare event that should be suspected in patients with persistent fever, pancytopenia and possible exposure to Leishmania spp., remembering that – as well as South-East Asia, East Africa and South America - it is endemic in several European regions.

KW - Bone marrow

KW - Fever

KW - Hematopoietic cell transplantation

KW - Leishmania spp.

KW - Pancytopenia

KW - Visceral leishmaniasis

UR - http://www.scopus.com/inward/record.url?scp=85051266889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051266889&partnerID=8YFLogxK

U2 - 10.1016/j.jiac.2018.05.008

DO - 10.1016/j.jiac.2018.05.008

M3 - Article

AN - SCOPUS:85051266889

JO - Journal of Infection and Chemotherapy

JF - Journal of Infection and Chemotherapy

SN - 1341-321X

ER -